Precision medicine and “Omics”

A Technological and Regulatory Challenge for the Public and Private Sectors

IFAB promotes projects in the field of precision medicine and life sciences. The integration of digital technologies in these areas can revolutionize the healthcare landscape, improve global well-being, and increase life expectancy and quality of life.

Opportunities of Precision Medicine

Thanks to AI and Supercomputing, “digital twins” become a reality: virtual representations of people will help predict and treat diseases in a personalized way, while the vast data processing capacity will make it possible to predict the risk of hereditary diseases.

Challenges and Obstacles

Achieving these goals requires overcoming numerous scientific challenges in the fields of biology, medicine, and engineering. Alongside these are technical, organizational, political, and ethical obstacles related to data access. In addition, inadequate technology transfer and regulatory systems can undermine research ideas and projects.

Public-Private Collaboration

A close collaboration between the public and private sectors is crucial for the development of precision medicine. The former is responsible for ensuring secure access to data, validation and certification of processes, and strict control of the systems. The latter must bring its expertise in the development of new technologies and medicines.

Progress and Innovation

Achievements are numerous and significant, such as the use of mRNA technologies (a key response to the Covid-19 pandemic) for cancer treatment. Current models based on AI and machine learning are accelerating drug development, disease diagnostics, and clinical trials. The path towards personalized medicine is rapidly taking shape.

Learn more about funded projects in this domain:

Stay updated on the latest IFAB events and projects.Subscribe to our monthly newsletter